Cargando…
An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging
Developing activatable fluorescent probes with superlative fluorescence enhancement factor (F/F (0)) to improve the signal‐to‐noise (S/N) ratio is still an urgent issue. “AND” molecular logic gates are emerging as a useful tool for enhanced probes selectivity and accuracy. Here, an “AND” logic gate...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131802/ https://www.ncbi.nlm.nih.gov/pubmed/36808894 http://dx.doi.org/10.1002/advs.202207066 |
_version_ | 1785031256570855424 |
---|---|
author | Sang, Mangmang Huang, Yibo Wang, Lu Chen, Lei Nawsherwan, Li, Gang Wang, Yan Yu, Xiu Dai, Cuilian Zheng, Jinrong |
author_facet | Sang, Mangmang Huang, Yibo Wang, Lu Chen, Lei Nawsherwan, Li, Gang Wang, Yan Yu, Xiu Dai, Cuilian Zheng, Jinrong |
author_sort | Sang, Mangmang |
collection | PubMed |
description | Developing activatable fluorescent probes with superlative fluorescence enhancement factor (F/F (0)) to improve the signal‐to‐noise (S/N) ratio is still an urgent issue. “AND” molecular logic gates are emerging as a useful tool for enhanced probes selectivity and accuracy. Here, an “AND” logic gate is developed as super‐enhancers for designing activatable probes with huge F/F (0) and S/N ratio. It utilizes lipid‐droplets (LDs) as controllable background input and sets the target analyte as variable input. The fluorescence is tremendously quenching due to double locking, thus an extreme F/F (0) ratio of target analyte is obtained. Importantly, this probe can transfer to LDs after a response occurs. The target analyte can be directly visualized through the spatial location without a control group. Accordingly, a peroxynitrite (ONOO(−)) activatable probe (CNP2‐B) is de novo designed. The F/F (0) of CNP2‐B achieves 2600 after reacting with ONOO(−). Furthermore, CNP2‐B can transfer from mitochondria to lipid droplets after being activated. The higher selectivity and S/N ratio of CNP2‐B are obtained than commercial probe 3'‐(p‐hydroxyphenyl) fluorescein (HPFin vitro and in vivo. Therefore, the atherosclerotic plaques at mouse models are delineated clearly after administration with in situ CNP2‐B probe gel. Such input controllable “AND” logic gate is envisioned to execute more imaging tasks. |
format | Online Article Text |
id | pubmed-10131802 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101318022023-04-27 An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging Sang, Mangmang Huang, Yibo Wang, Lu Chen, Lei Nawsherwan, Li, Gang Wang, Yan Yu, Xiu Dai, Cuilian Zheng, Jinrong Adv Sci (Weinh) Research Articles Developing activatable fluorescent probes with superlative fluorescence enhancement factor (F/F (0)) to improve the signal‐to‐noise (S/N) ratio is still an urgent issue. “AND” molecular logic gates are emerging as a useful tool for enhanced probes selectivity and accuracy. Here, an “AND” logic gate is developed as super‐enhancers for designing activatable probes with huge F/F (0) and S/N ratio. It utilizes lipid‐droplets (LDs) as controllable background input and sets the target analyte as variable input. The fluorescence is tremendously quenching due to double locking, thus an extreme F/F (0) ratio of target analyte is obtained. Importantly, this probe can transfer to LDs after a response occurs. The target analyte can be directly visualized through the spatial location without a control group. Accordingly, a peroxynitrite (ONOO(−)) activatable probe (CNP2‐B) is de novo designed. The F/F (0) of CNP2‐B achieves 2600 after reacting with ONOO(−). Furthermore, CNP2‐B can transfer from mitochondria to lipid droplets after being activated. The higher selectivity and S/N ratio of CNP2‐B are obtained than commercial probe 3'‐(p‐hydroxyphenyl) fluorescein (HPFin vitro and in vivo. Therefore, the atherosclerotic plaques at mouse models are delineated clearly after administration with in situ CNP2‐B probe gel. Such input controllable “AND” logic gate is envisioned to execute more imaging tasks. John Wiley and Sons Inc. 2023-02-19 /pmc/articles/PMC10131802/ /pubmed/36808894 http://dx.doi.org/10.1002/advs.202207066 Text en © 2023 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Sang, Mangmang Huang, Yibo Wang, Lu Chen, Lei Nawsherwan, Li, Gang Wang, Yan Yu, Xiu Dai, Cuilian Zheng, Jinrong An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging |
title | An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging |
title_full | An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging |
title_fullStr | An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging |
title_full_unstemmed | An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging |
title_short | An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging |
title_sort | “and” molecular logic gate as a super‐enhancers for de novo designing activatable probe and its application in atherosclerosis imaging |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131802/ https://www.ncbi.nlm.nih.gov/pubmed/36808894 http://dx.doi.org/10.1002/advs.202207066 |
work_keys_str_mv | AT sangmangmang anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT huangyibo anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT wanglu anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT chenlei anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT nawsherwan anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT ligang anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT wangyan anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT yuxiu anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT daicuilian anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT zhengjinrong anandmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT sangmangmang andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT huangyibo andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT wanglu andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT chenlei andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT nawsherwan andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT ligang andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT wangyan andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT yuxiu andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT daicuilian andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging AT zhengjinrong andmolecularlogicgateasasuperenhancersfordenovodesigningactivatableprobeanditsapplicationinatherosclerosisimaging |